SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gator II who wrote (1015)5/4/1999 8:59:00 AM
From: Scott H. Davis  Read Replies (1) of 1972
 
Possibly, but over the past 1.5 years I've seriously followed VICL, I have not seen much market response to VICL earning statements. The most relevent item in the releases to me is the cash & burn rate. With VICL, the burn rate has been very low for d development stage biotech, especially with this many phase II & III trials going on.
At -.05, this is a materially smaller loss than the last 4 qtrs.
IMSCO Scott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext